UK markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.04+0.28 (+4.86%)
At close: 04:00PM EDT
6.03 -0.01 (-0.17%)
After hours: 07:43PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.76
Bid6.01 x 900
Ask6.02 x 1400
Day's range5.71 - 6.13
52-week range5.61 - 82.30
Avg. volume6,775,821
Market cap520.486M
Beta (5Y monthly)1.78
PE ratio (TTM)N/A
EPS (TTM)-8.50
Earnings date08 May 2023 - 12 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est50.80
  • Zacks

    Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know

    In the latest trading session, Novavax (NVAX) closed at $5.76, marking a -0.35% move from the previous day.

  • Motley Fool

    Why Novavax Stock Slipped on Thursday

    The departing party is Greg Glenn, the president of research and development. First, research and development is a crucial area for biotechs like Novavax, as their future is heavily dependent on their pipeline programs. Second, Glenn was a longtime company mainstay, having joined Novavax in 2010.

  • Motley Fool

    1 Green Flag and 1 Red Flag for Novavax

    Novavax (NASDAQ: NVAX) has had more than its share of ups and downs over the past few years -- and investors have been along for the ride. The stock soared 2,700% in 2020 as the company brought its coronavirus vaccine candidate through late-stage clinical trials. The biotech company's vaccine reached commercialization later than rivals.